DHFR gene amplification in cultured skin fibroblasts of ataxia telangiectasia patients after methotrexate selection

Christine Lücke-huhle, Susanne Hinrichs, Günter Speit

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

During selection for methotrexate resistance, SV40-transformed human skin fibroblasts from patients with ataxia telangiectasia (A-T) underwent amplification of the dihydrofolate reductase (DHFR) gene, experienced nearly complete loss of the integrated SV40 sequences and showed a 3.6-fold increase in Ki-ras gene copy number. Over a period of months methotrexate-resistant (MTXr) A-T subclones were obtained, which were able to grow in progressively increasing MTX concentrations up to 100 μM. The ED50 values determined as the effective dose of MTX causing 50% growth inhibition in comparison to control cells increased from 3×10-2 μM for MTXs AT5BI-VA cells to 250 μM MTX for the MTXr AX100 subclone. In contrast, human skin fibroblasts of healthy individuals did not show DHFR gene amplification and loss of SV40 sequences under comparable conditions and were unable to grow in MTX concentrations >1 μM. Gene amplification and loss of DNA sequences are features underlying the genomic instability known to be a characteristic property of A-T cells and being probably responsible for the high cancer incidence in these patients.

Original languageEnglish (US)
Pages (from-to)1801-1806
Number of pages6
JournalCarcinogenesis
Volume8
Issue number12
DOIs
StatePublished - Dec 1 1987

Fingerprint

Ataxia Telangiectasia
Tetrahydrofolate Dehydrogenase
Gene Amplification
Methotrexate
Fibroblasts
Skin
Gene Dosage
ras Genes
Genomic Instability
Incidence
Growth
Genes
Neoplasms

ASJC Scopus subject areas

  • Cancer Research

Cite this

DHFR gene amplification in cultured skin fibroblasts of ataxia telangiectasia patients after methotrexate selection. / Lücke-huhle, Christine; Hinrichs, Susanne; Speit, Günter.

In: Carcinogenesis, Vol. 8, No. 12, 01.12.1987, p. 1801-1806.

Research output: Contribution to journalArticle

@article{87f4662ff36047dda443daac8ba55a81,
title = "DHFR gene amplification in cultured skin fibroblasts of ataxia telangiectasia patients after methotrexate selection",
abstract = "During selection for methotrexate resistance, SV40-transformed human skin fibroblasts from patients with ataxia telangiectasia (A-T) underwent amplification of the dihydrofolate reductase (DHFR) gene, experienced nearly complete loss of the integrated SV40 sequences and showed a 3.6-fold increase in Ki-ras gene copy number. Over a period of months methotrexate-resistant (MTXr) A-T subclones were obtained, which were able to grow in progressively increasing MTX concentrations up to 100 μM. The ED50 values determined as the effective dose of MTX causing 50{\%} growth inhibition in comparison to control cells increased from 3×10-2 μM for MTXs AT5BI-VA cells to 250 μM MTX for the MTXr AX100 subclone. In contrast, human skin fibroblasts of healthy individuals did not show DHFR gene amplification and loss of SV40 sequences under comparable conditions and were unable to grow in MTX concentrations >1 μM. Gene amplification and loss of DNA sequences are features underlying the genomic instability known to be a characteristic property of A-T cells and being probably responsible for the high cancer incidence in these patients.",
author = "Christine L{\"u}cke-huhle and Susanne Hinrichs and G{\"u}nter Speit",
year = "1987",
month = "12",
day = "1",
doi = "10.1093/carcin/8.12.1801",
language = "English (US)",
volume = "8",
pages = "1801--1806",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - DHFR gene amplification in cultured skin fibroblasts of ataxia telangiectasia patients after methotrexate selection

AU - Lücke-huhle, Christine

AU - Hinrichs, Susanne

AU - Speit, Günter

PY - 1987/12/1

Y1 - 1987/12/1

N2 - During selection for methotrexate resistance, SV40-transformed human skin fibroblasts from patients with ataxia telangiectasia (A-T) underwent amplification of the dihydrofolate reductase (DHFR) gene, experienced nearly complete loss of the integrated SV40 sequences and showed a 3.6-fold increase in Ki-ras gene copy number. Over a period of months methotrexate-resistant (MTXr) A-T subclones were obtained, which were able to grow in progressively increasing MTX concentrations up to 100 μM. The ED50 values determined as the effective dose of MTX causing 50% growth inhibition in comparison to control cells increased from 3×10-2 μM for MTXs AT5BI-VA cells to 250 μM MTX for the MTXr AX100 subclone. In contrast, human skin fibroblasts of healthy individuals did not show DHFR gene amplification and loss of SV40 sequences under comparable conditions and were unable to grow in MTX concentrations >1 μM. Gene amplification and loss of DNA sequences are features underlying the genomic instability known to be a characteristic property of A-T cells and being probably responsible for the high cancer incidence in these patients.

AB - During selection for methotrexate resistance, SV40-transformed human skin fibroblasts from patients with ataxia telangiectasia (A-T) underwent amplification of the dihydrofolate reductase (DHFR) gene, experienced nearly complete loss of the integrated SV40 sequences and showed a 3.6-fold increase in Ki-ras gene copy number. Over a period of months methotrexate-resistant (MTXr) A-T subclones were obtained, which were able to grow in progressively increasing MTX concentrations up to 100 μM. The ED50 values determined as the effective dose of MTX causing 50% growth inhibition in comparison to control cells increased from 3×10-2 μM for MTXs AT5BI-VA cells to 250 μM MTX for the MTXr AX100 subclone. In contrast, human skin fibroblasts of healthy individuals did not show DHFR gene amplification and loss of SV40 sequences under comparable conditions and were unable to grow in MTX concentrations >1 μM. Gene amplification and loss of DNA sequences are features underlying the genomic instability known to be a characteristic property of A-T cells and being probably responsible for the high cancer incidence in these patients.

UR - http://www.scopus.com/inward/record.url?scp=0023616884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023616884&partnerID=8YFLogxK

U2 - 10.1093/carcin/8.12.1801

DO - 10.1093/carcin/8.12.1801

M3 - Article

C2 - 2824082

AN - SCOPUS:0023616884

VL - 8

SP - 1801

EP - 1806

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 12

ER -